MDAI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MDAI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Spectral AI's revenue for the three months ended in Dec. 2024 was $7.60 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $29.58 Mil. Spectral AI's Revenue per Share for the three months ended in Dec. 2024 was $0.39. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $1.65.
During the past 12 months, the average Revenue per Share Growth Rate of Spectral AI was 28.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 4 years, Spectral AI's highest 3-Year average Revenue per Share Growth Rate was 19.30% per year. The lowest was 19.30% per year. And the median was 19.30% per year.
The historical data trend for Spectral AI's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI Annual Data | |||||||||
Trend | Dec21 | Dec22 | Dec23 | Dec24 | |||||
Revenue | 15.24 | 25.37 | 18.06 | 29.58 |
Spectral AI Quarterly Data | ||||||||||||
Dec21 | Mar22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Revenue | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
5.29 | 6.33 | 7.48 | 8.17 | 7.60 |
For the Medical Devices subindustry, Spectral AI's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's Revenue distribution charts can be found below:
* The bar in red indicates where Spectral AI's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $29.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI (NAS:MDAI) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Thank you for viewing the detailed overview of Spectral AI's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
John Michael Dimaio | 10 percent owner | 6125 LUTHER LANE, DALLAS TX 75225 |
Michael Patrick Murphy | director | 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153 |
Els 1960 Family, L.p. | 10 percent owner | 2323 VICTORY AVE., SUITE. 700, DALLAS TX 75219 |
Richard John Cotton | director | RUE DU VILLAGE 4, CHAMPERY V8 1874 |
Mellish Martin C.b. | director | 13 BERRILL FARMS LN, HANOVER NH 03755 |
Jeffrey Edward Thatcher | officer: Chief Scientist | 6659 ESCONDIDO ST, IRVING TX 75039 |
Nils Windler | officer: Chief Financial Officer | 8602 NAPA LANDING, SAN ANTONIO TX 78015 |
Wensheng Fan | director, officer: CHIEF EXECUTIVE OFFICER | 3320 SPRING MOUNTAIN DRIVE, PLANO TX 75025 |
Vincent S. Capone | officer: GENERAL COUNSEL | 1620 GRASSHOPPER LANE, LOWER GWYNEDD PA 19002 |
Nikolaos Pagoulatos | officer: CHIEF OPERATING OFFICER | 5122 IROQUOIS DR, FRISCO TX 75034 |
Xiaojia Cynthia Cai | director | 10 CELESTIAL WAY, NEWARK DE 19711 |
Heather Bellini | director | 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153 |
Edmonds Franklin S. Jr. | director | 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153 |
Rosecliff Acquisition Sponsor I Llc | director | 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153 |
Erich Spangenberg | 10 percent owner | 73 595 EL PASEO, SUITE 2204, PALM DESERT CA 92260 |
From GuruFocus
By Marketwired • 10-30-2024
By GlobeNewswire • 12-13-2024
By GuruFocus News • 11-05-2024
By Marketwired • 12-02-2024
By Marketwired • 02-28-2025
By Marketwired • 11-19-2024
By Marketwired • 01-22-2025
By Marketwired • 10-14-2024
By Marketwired • 02-28-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.